Venn Life Sciences is a Dublin, Ireland consultancy providing drug development services to pharmaceutical and biotech companies.
Founded in 2012 in Dublin, Ireland, Venn Life Sciences offers drug development consultancy, including clinical trial design, regulatory affairs, medical writing, data management and project management. Its clients include biotechnology and pharmaceutical companies, mainly in Europe and North America. Calculus Capital invested in the company in 2012, and Tony Richardson is CEO. The company reported revenue of USD 414,105.80 and EBITDA of USD -296,402.60 in 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in